Hepatitis

News13 May 2024

Zimbabwe: Harm reduction strategy key in curbing liver damage from drug, substance use

Mr Wilson Box of the Zimbabwe Civil Liberties and Drug Network (ZCLDN) underscores the importance of decriminalisation as an essential component of the harm reduction approach to curb liver-related diseases

Publications17 April 2024

Values and preferences study: Communicable diseases and people who use drugs in Europe

EuroNPUD explore community-led communicable disease testing and care integration for people who use drugs, assessing best practice and attitudes surrounding these services.

Publications11 April 2024

United for change: Advocacy strategy for comprehensive health and harm reduction services for people who use drugs in Europe

The BOOST project seeks to combat HIV/AIDS and viral hepatitis in Europe through community-led harm reduction initiatives, aiming to enhance health services for people who use drugs and marginalised populations.

Publications1 February 2024

Eliminating hepatitis C in Europe: Report on policy implementation for people who inject drugs

C-EHRN argues for coordinated, context-dependent, and well-funded responses, including harm reduction strategies, to achieve the 2030 elimination goal.

Events

12th International Conference on Health and Hepatitis Care in Substance Users - INHSU 2024

Athens, Greece

8 October 2024 - 11 October 2024

Abstracts that focus on health issues among people who use drugs beyond hepatitis C are not only welcomed but highly encouraged.

Publications30 November 2023

Prevention and control of infectious diseases among people who inject drugs — 2023 update

The EMCDDA provide updated guidance to policy-makers and public health providers on developing strategies to prevent and control the spread of blood-borne infections among people who inject drugs.

News5 September 2023

Connecting with Care - Portugal

INHSU go behind the scenes of three harm reduction organisations in Lisbon - CRESCER, GAT, and Ares do Pinhal, who provide vital harm reduction services such as Hepatitis C testing and treatment in safe and inclusive community-based settings.

Events

Integrating viral hepatitis and harm reduction services

Online

5 September 2023

This webinar will showcase models of harm reduction and viral hepatitis testing, treatment, and care integration.

Publications15 August 2023

Harm reduction best and worst practice: Peer-informed policy and program recommendations in the time of Covid-19

INPUD present a best-practice toolkit, focused on key harm reduction interventions, based on interviews with twenty peer drug user activists and harm reduction specialists from a range of different countries.

Publications3 July 2023

Out of sight: Women who inject drugs and access to harm reduction in Nepal

Mainline review the current harm reduction programmes in Nepal from the perspective of women who inject drugs, and formulate recommendations to improve service delivery.

Publications3 July 2023

European Drug Report 2023: Trends and developments

The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.

Publications9 June 2023

CHECK magazine - Women who use drugs - 3rd issue

EHRA publish their latest edition of CHECK magazine, focusing on the disproportionate levels of stigmatisation and discrimination that women who use drugs face as a result of existing gender inequalities and prohibitionist policies.

Explore more content